Research in people using GLP-1s for obesity shows: Nausea, vomiting, diarrhea and constipation are the leading side effects.Nature+1 The risk of these symptoms typically increases with dose, especially during dose escalation.Nature+1 Constipation in particular is reported more often in obesity trials than in diabetes trials.Taylor & Francis Online+1 In everyday language: your digestive system is being asked to slow down and adjust, while your eating patterns and appetite are changingsometimes dramatically and quickly
GLP-1 drug usage was associated with a reduced risk of just about everything bad: substance use and psychotic disorders, seizures, neuro-cognitive disorders (including Alzheimers disease and dementia), coagulation disorders [e.g., means clotting], cardio-metabolic disorders, infectious illnesses and several respiratory conditions. When I initially read this study in January, it seemed too good to be true
As we mentioned before, when your skin tans, it means its responding to injury
Verfeinern Sie Rohkostspeisen gelegentlich mit Leinl und nehmen Sie die langkettigen Fettsuren EPA und DHA in Form von Algenl ein
About 47% lost at least 10% of body weight
For dosing conventions used in research, see the GHK-Cu dosage reference